Adverse drug reactions of nonsteroidal anti-inflammatory drugs in orthopedic patients

Journal of Pharmacology and Pharmacotherapeutics

Volumn 2, Issue 1, 2011, Pages 26-29

  Gor, Alpa Pragnesh ^a   Saksena, Miti ^a  

^a Pramukh Swami Medical College   (India)

Author keywords

Adverse drug reaction; nonsteroidal anti inflammatory drug; pharmacovigilance

Indexed keywords

DICLOFENAC; ETORICOXIB; IBUPROFEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM;

ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDICS; PRESCRIPTION; RISK ASSESSMENT; SEX DIFFERENCE; UNSPECIFIED SIDE EFFECT;

EID: 84857559117     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.77104     Document Type: Article

References (24)

1. Dhikav V, Singh S, Anand KS. Newer non-steroidal anti-inflammatory drugs: A review of their therapeutic potential and adverse drug reactions. J Indian Acad Commun Med 2002;3:332-8.
2. Lipsy P. The role of cyclooxygenase-2-specific inhibitors in clinical practice. Am J Med 2001;110:1-5.
3. Pincus T, Swearingen C, Cummine P, Callahaw L P. Preference for non-steroidal anti-inflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000;27:1020-7.
4. Singh G, Ramey DR, Morfeld D, Shi H, Hatoum H T, Fries J F. Gastrointestinal tract complications of Non-steroidal anti-inflammatory drug treatment in rheumatoid arthritis: A prospective observational cohort study. Arch Intern Med 1996;156;1530-6.
5. Shah AA, Thjodleifsson B, Murray FE, Kay E, Barry M, Sigthorsson G, et al. Selective inhibition of Cox-2 in humans is associated with less gastrointestinal injury: A comparision of nimesulide and naproxen. Gut 2001;48:339-46.
6. Rainsford KD, Veto G P. Side-effects of anti-Inflammatory drugs: Clinical and Epidemiological Agents. 1983.
7. Rainsford KD, Veto G P. Side-effects of anti-Inflammatory drugs: Clinical and Epidemiological Agents. 1987.
8. Rainsford KD, Veto G P. Side-effects of anti-inflammatory drugs. 3rd ed. Ktuwer Academic Publishers; 1992.
9. Rainsford KD. Profile and mechanisms of gastrointestinal and other side-effects from NSAIDs. Am J Med 1999;107:27-36.
10. Simon RA, Namazy J. Adverse reactions to aspirin and nonsteroidal antiinflammatory drugs (NSAIDs). Clin Rev Allergy Immunol 2003;24:239-52.
11. Day R. COX-2: Where are we in 2003? Distinction from NSAIDs becoming blurred. Arthritis Res Ther 2003;5:116-9.
12. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs. Clin Rev Allergy Immunol 2003;24:125-36.
13. Rainsford KD. Mechanisms of rash formation and related skin conditions induced by non-steroidal anti-inflammatory drugs. Kluwer Academic Publishers; 1992. p. 287-301.
14. Sturkenboom M, Nicolosi A, Cantarutti L, Mannino S, Picelli G, Scamarcia A, et al. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics 2005;116:26-33.
15. Rainsford KD. Relationship of nimesulide safety to its pharmacokinetics: Assessment of adverse Reactions. Rheumatology 1999;38:4-10.
16. Tubert P, Bégaud B, Péré JC, Haramburu F, Lellouch J. Power and weakness of spontaneous reporting: A probabilistic approach. J Clin Epidemiol 1992;45:283-6.
17. Shahani S, Nerlekar S. Adverse drug reactions in dermatology and a growing need for pharmacovigilance. J Pharmacovig Drug Saf 2009;6:35-7.
18. Fry RB, Ray MN, Cobangn DJ, Weissman N W. Racial /ethnic disparities in patient - reported non-steroidal anti-inflammatory drug (NSAIDs) risk awareness, patient - doctor NSAID risk communication and NSAID risk behavior. Arthritis 2007;57:1539-45.
19. Shi W, Wang YM, Li SL, Yan M, Li D, Chen BY, et al. Risk factor of adverse drug reaction from non-steroidal anti-inflammatory drugs in shanghi patients with arthropathy. Acta Pharmacol Sin 2004;25:357-65.
20. Miceli-Richard C, Le Bars M, Schmidely N, Dougados M. Paracetamol in osteoarthritis of the knee. Ann Rheum Dis 2004;63:923-30.
21. Boelsterli UA. Diclofenac induced liver injury: A paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol 2003;192:307-22.
22. Sulleyman H, Cardirci E, Albayrak A, Hallici Z. Nimesulide is a selective cox-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr Med Chem 2008;15:278-83.
23. Hunt RH. Gastrointestinal safety profile of etoricoxib. Aliment Pharmacol Ther 2003;17:201-10.
24. Zopf Y, Rabe C, Neubert A, Gassmann KG, Rascher W, Hahn EG, et al. Women encounter ADRs more than do men. Eur J Clin Pharmacol 2008;64:999-1004.